MYC and cancer: Our data lend credence to the hypothesis that such compounds may repress cMYC‐driven expression of ribosomal and translational machinery, and may therefore synergistically enhance the efficacy of inhibitors that directly target the ribosome, in development for cancer chemotherapy.21, 22